Even more curious in light of Peter's observation[#915]:
">>FreeStyle Libre continuous glucose-monitoring system
From their website:
Quote: 40% of the time when the device indicated that user sensor glucose values were at or below 60 mg/dL, user glucose values were actually in the range of 81–160 mg/dL"
My spouse[a M.D., J.D. with near 30 years experience in FDA regulatory matters] read that last night, and wondered how the device was approved in the first place.
Media and analysts seem unaware of Peter's observation. OTOH, perhaps the ABT website is out of date, and the problem with the device has been fixed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.